Yoshida, Shota http://orcid.org/0000-0002-6830-7063
Nakagami, Hironori http://orcid.org/0000-0003-4494-3601
Hayashi, Hiroki http://orcid.org/0000-0001-5722-3764
Ikeda, Yuka
Sun, Jiao http://orcid.org/0000-0001-8843-381X
Tenma, Akiko
Tomioka, Hideki http://orcid.org/0000-0001-5766-6338
Kawano, Tomohiro
Shimamura, Munehisa http://orcid.org/0000-0003-0374-0787
Morishita, Ryuichi http://orcid.org/0000-0002-8855-0730
Rakugi, Hiromi http://orcid.org/0000-0001-6508-4338
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (JP15K15310)
Article History
Received: 4 January 2019
Accepted: 22 April 2020
First Online: 18 May 2020
Competing interests
: Department of Health Development and Medicine is endowed department supported by Anges, Daicel, and Funpep. Department of Clinical Gene Therapy is financially supported by Novartis, AnGes, Shionogi, Boeringher, Fancl, Saisei Mirai Clinics, Rohto and Funpep. R.M. is a stockholder of FunPep and AnGes. H.T. and A.T. are employees and stockholders of FunPep. The funder (Funpep) provided support in the form of salaries for authors (H.T. and A.T.) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All other authors declare no competing interests.